6
Tetrahedron
ACCEPTED MANUSCRIPT
6.95 (s, 1H, CONH2), 7.26-8.11 (m, 21H, triazole, 4 Bz
3.89 (m, 2H, H-2”, H-6”), 4.58 (s, 2H, H-8’), 5.55 (t, 1H, J = 9.2
aromatics). 13C-NMR (125 MHz, CDCl3): δ = 12.7, 12.8 (19, 19’,
20-Me), 14.7 (20’-Me), 19.2 (C-3), 20.8 (CH2-C=C propanoyl),
21.7 (C-18), 28.9 (16, 17-Me), 33.0, 33.2, 34.2 (C-1, C-4, CH2-
CO), 39.6 (C-2), 62.4 (C-6”), 70.0 (C-8’), 68.2, 71.1, 72.3, 73.9
(C-2”-C-5”), 89.2 (C-1”), 120.2, 123.3, 125.1, 126.6, 137.1 (CH
triazole, C-7, 8’, 10, 10’, 11, 11’, 12, 12’, 14, 14’, 15, 15’),
128.2-133.6 (Bz aromatics), 129.3, 131.6, 135.7, 136.0, 136.7,
137.8 (C-5, 6, 9, 9’, 13, 13’), 146.4 (C=CH triazole), 164.2,
164.9, 165.0, 166.0, 166.4 (4 Bz C=O, CONH2), 172.1 (C=O,
propanoyl). MS (MALDI-TOF, negative mode, without matrix)
m/z = 1161.6 (M+-1). Anal. calcd. for C70H74N4O12: C 72.27, H
6.41, N 4.82, found C 72.48, H 6.59, N 4.66.
Hz, H-1”), 6.10-6.73 (m, 12H, H-7, 8, 10, 10’, 11, 11’, 12, 12’,
14, 14’, 15, 15’), 7.97 (s, 1H, triazole). 13C-NMR (125 MHz,
CD3OD + CDCl3): δ = 13.0 (19, 19’, 20-Me), 14.9 (20’-Me), 20.1
(C-3), 21.6 (CH2-C=C propanoyl), 22.0 (18-Me), 29.4 (16, 17-
Me), 33.8, 34.2, 35.0 (C-1, C-4, CH2-CO), 40.5 (C-2), 62.2 (C-
6”), 71.0 (C-8’), 70.5, 73.7, 78.1, 80.6 (C-2”, 3”, 4”, 5”), 89.2 (C-
1”), 122.3, 124.2, 126.0, 127.4, 130.1, 130.7, 131.4, 131.8, 133.2,
133.9, 138.2, 138.9, 139.4 (CH triazole, C-7, 8’, 10, 10’, 11, 11’,
12, 12’, 14, 14’, 15, 15’), 132.5, 136.6, 137.5 (C-5, 6, 9, 9’, 13,
13’), 147.1 (C=CH triazole), 173.7 (C=O, propanoyl). MS
(MALDI-TOF, positive mode, with DHB matrix) m/z = 703.52
(M+). Anal. calcd. for C41H57N3O7: C 69.96, H 8.16, N 5.97,
found C 69.73, H 7.93, N 5.72.
4.8. 6”-deoxy-6”-(4-(3-(8’-apo-β-caroten-8’-yloxy)-3-
oxopropyl)-1,2,3-triazol-1-yl)-1”,2”,3”,4”-tetra-O-acetyl-α-d-
glucopyranose (18)
4.10. 8’-(1-(1”-carboxamido-β-d-glucopyranosyl)-1,2,3-triazol-
4-yl)-propanoyloxy)-8’-apo-β-carotene (20)
Following the general procedure, 8’-apo-β-carotenol
pentynoate (5, 45 mg, 0.09 mmol) was dissolved in dry
dichloromethane (2 mL) with 6-deoxy-6-azido-1,2,3,4-tetra-O-
Following the general procedure, 8’-apo-β-carotenol
pentynoate (5, 30 mg, 0.06 mmol) was dissolved in dry
dichloromethane (1 mL) with 1-carboxamido-β-D-glucopyranosyl
acetyl-α-D-glucopyranose (12, 34 mg, 0.09 mmol) and
azide (14, 15 mg, 0.06 mmol) and C3H7COOCu(PPh3)2 (2 mg,
0.003 mmol). After stirring for 2 days under nitrogen atmosphere
in darkness, the solvent was evaporated under reduced pressure,
and the residue was purified by preparative thin layer
chromatography (SiO2, CH2Cl2–MeOH, 9:1). Yield: 22 mg
(49%); red syrup; Rf = 0.70 (CH2Cl2–MeOH, 4:1). 1H-NMR (500
MHz, CD3OD): δ = 1.03 (s, 6H, 16, 17-Me), 1.48-1.50 (m, 2H,
H-2), 1.63-1.65 (m, 2H, H-3), 1.71, 1.82 (2s, 6H, Me-18,20’),
1.95, 1.96, 1.97 (3s, 9H, 19, 19’, 20-Me), 2.04 (t, 2H, J = 6.1 Hz,
H-4), 2.78 (t, 2H, J = 7.4 Hz, CH2 propanoyl), 3.04 (t, 2H, J = 7.4
Hz, CH2 propanoyl), 3.48-3.79 (m, 4H, H-3”, 4”, 5”, 6”), 3.91
(dd, 1H, J = 1.5 Hz, J = 12.2 Hz, H-6”), 4.00 (d, 1H, J = 9.8 Hz,
H-2”), 4.58 (s, 2H, H-8), 6.09-6.72 (m, 12H, H-7, 8, 10, 10’, 11,
11’, 12, 12’, 14, 14’, 15, 15’), 8.07 (s, 1H, triazole). 13C-NMR
(125 MHz, CD3OD): δ = 12.8, 12.9, 14.8 (19, 19’, 20, 20’-Me),
20.4 (C-3), 21.9 (CH2-C=C propanoyl), 22.0 (C-18), 29.5 (16,
17-Me), 34.0, 34.4, 35.3 (C-1, C-4, CH2-CO), 40.9 (C-2), 62.3
(C-6”), 71.2 (C-8’), 70.5, 76.0, 77.2, 79.5 (C-2”-C-5”), 90.6 (C-
1”), 122.3, 124.6, 126.2, 127.6, 130.3, 131.7, 132.3, 133.7, 134.2,
137.8, 138.7, 139.5, 139.7 (CH triazole, C-7, 8’, 10, 10’, 11, 11’,
12, 12’, 14, 14’, 15, 15’), 130.1, 133.1, 136.8, 137.0, 139.3 (C-5,
6, 9, 9’, 13, 13’), 147.5 (C=CH triazole), 169.4 (CONH2), 174.0
(C=O, propanoyl). MS (MALDI-TOF, positive mode, with DHB
matrix) m/z = 747.1 (M+). Anal. calcd. for C42H58N4O8: C 67.54,
H 7.83, N 7.50, found C 67.86, H 8.09, N 7.36.
C3H7COOCu(PPh3)2 (3 mg, 0.004 mmol). After stirring for 8 h
under nitrogen atmosphere in darkness, the solvent was
evaporated under reduced pressure, and the residue was purified
by column chromatography (SiO2, EtOAc–hexane, 1:1). Yield:
50 mg (63%); orange amorphous product; Rf = 0.19 (EtOAc–
1
hexane, 1:1). H-NMR (500 MHz, CDCl3): δ = 1.01 (s, 6H, 16,
17-Me), 1.43-4.47 (m, 2H, H-2), 1.58-1.62 (m, 2H, H-3), 1.70,
1.81 (2s, 6H, Me-18, 20’), 1.93-2.10 (m, 23H, H-4, Me-19, 19’,
20-Me, 4 Ac-Me), 2.76 (t, 2H, J = 7.4 Hz, CH2 propanoyl), 3.04
(t, 2H, J = 7.3 Hz, CH2 propanoyl), 4.23-4.37 (m, 2H, H-5”, H-
6”), 4.50-4.55 (m, 3H, H-8’, H-6”), 4.81 (t, 1H, J = 9.6 Hz, H-
2”/4”), 5.01 (dd, 1H, J = 3.7 Hz, J = 10.3 Hz, H-4”/2”), 5.45 (t,
1H, J = 9.8 Hz, H-3”), 6.09-6.68 (m, 13H, H-1”, H-7, 8, 10, 10’,
11, 11’, 12, 12’, 14, 14’, 15, 15’), 7.41 (s, 1H, triazole). 13C-NMR
(125 MHz, CDCl3): δ = 12.7, 12.8 (19, 19’, 20-Me), 14.7 (20’-
Me), 19.2 (C-3), 20.4, 20.6, 20.6, 20.7, 21.7 (4 Ac-Me, C-18),
21.0 (CH2-C=C propanoyl), 28.9 (16, 17-Me), 33.06, 33.52,
34.22 (C-1, C-4, CH2-CO), 39.59 (C-2), 50.26 (C-6”), 69.0, 69.2,
69.5, 70.3 (C-2”-C-5”), 69.9 (C-8’), 88.6 (C-1”), 122.7, 123.3,
125.1, 126.7, 129.0, 129.6, 130.4, 130.7, 132.2, 132.9, 137.1,
137.7, 138.4 (CH triazole, C-7, 8’, 10, 10’, 11, 11’, 12, 12’, 14,
14’, 15, 15’), 129.3, 131.8, 135.7, 136.1, 136.7, 137.8 (C-5, 6, 9,
9’, 13, 13’), 146.6 (C=CH triazole), 168.6, 169.4, 169.6, 170.0 (4
Ac C=O), 172.3 (C=O, propanoyl). MS (MALDI-TOF, positive
mode, with DHB matrix) m/z = 871.4 (M+). Anal. calcd. for
C49H65N3O11: C 67.49, H 7.51, N 4.82, found C 67.71, H 7.50, N
4.93.
4.11. 3,3’-bis(1-(β-d-glucopyranosyl)-1,2,3-triazol-4-yl)-
propanoyloxy)-β,β-carotene (21)
Following the general procedure, zeaxanthin dipentynoate (6,
30 mg, 0.04 mmol) was dissolved in dry dichloromethane (1 mL)
with β-D-glucopyranosyl azide (13, 8.5 mg, 0.04 mmol) and
4.9. 8’-(1-(β-d-glucopyranosyl)-1,2,3-triazol-4-yl)-
propanoyloxy)-8’-apo-β-carotene (19)
Following the general procedure, 8’-apo-β-carotenol
pentynoate (5, 30 mg, 0.06 mmol) was dissolved in dry
dichloromethane (1 mL) with β-D-glucopyranosyl azide (13, 12
C3H7COOCu(PPh3)2 (1.4 mg, 0.002 mmol). After stirring for 12
h under nitrogen atmosphere in darkness, the solvent was
evaporated under reduced pressure, and the residue was purified
by preparative thin layer chromatography (SiO2, CH2Cl2–MeOH,
9:1). Yield: 30 mg (65%); orange plate crystals; mp: 198-199 °C;
Rf = 0.34 (CH2Cl2–MeOH, 4:1). 1H-NMR (500 MHz, (CD3)2SO):
δ = 1.06, 1.08 (2s, 12H, 16, 16’, 17, 17’-Me), 1.53 (t, 2H, J =
11.4 Hz, H-2, 2’ax), 1.71 (s, 6H, 18, 18’-Me), 1.75-1.78 (m, 2H,
H-2, 2’eq), 1.94 (s, 12H, Me-19, 19’, 20, 20’-Me), 2.10-2.15 (m,
2H, H-4, 4’ax), 2.37-2.41 (m, 2H, H-4, 4’eq), 2.68 (brs, 4H, CH2
propanoyl), 2.90 (brs, 4H, CH2 propanoyl), 3.20-3.71 (m, 12H,
H-2”, 3”, 4”, 5”, 2x6”), 4.65 (brs, 2H, OH), 4.98 (brs, 2H, H-3,
3’), 5.24 (brs, 2H, OH), 5.41 (brs, 2H, OH), 5.47 (d, 2H, J = 9.0
Hz, H-1”), 6.10-6.26 (m, 6H, H-7, 7’, 8, 8’, 10, 10’), 6.33-6.42
(m, 4H, H-12, 12’, 14, 14’), 6.64-6.72 (m, 4H, 11, 11’, 15, 15’),
mg, 0.06 mmol) and C3H7COOCu(PPh3)2 (2 mg, 0.003 mmol).
After stirring for 1 day under nitrogen atmosphere in darkness,
the solvent was evaporated under reduced pressure, and the
residue was purified by column chromatography (SiO2, CH2Cl2–
MeOH, 95:5). Yield: 30 mg (72%); orange plate crystals; mp:
147-148 °C; Rf = 0.75 (CH2Cl2–MeOH, 4:1). 1H-NMR (500
MHz, CD3OD): δ = 1.04 (s, 6H, 16, 17-Me), 1.48-1.51 (m, 2H,
H-2), 1.62-1.66 (m, 2H, H-3), 1.71 (s, 3H, Me-18), 1.82 (s, 3H,
Me-20’), 1.96, 1.97, 1.98 (3s, 6H, Me-19, 19’, 20-Me), 2.04 (t,
2H, J = 6.1 Hz, H-4), 2.78 (t, 2H, J = 7.4 Hz, CH2 propanoyl),
3.05 (t, 2H, J = 7.4 Hz, CH2 propanoyl), 3.48-3.57 (m, 3H, H-3”,
H-4”, H-5”), 3.71 (dd, 1H, J = 5.4 Hz, J = 12.1 Hz, H-6”), 3.85-